Toremifene (NSC 613680; NK 622; FC 1157a) is an orally bioavailable and second-generation SERM (selective estrogen receptor modulator) used in the treatment of advanced breast cancer.

Raloxifene HCl (also known as LY-156758; LY-139481; trade names: Evista; Keoxifene; RALOX), the hydrochloride salt of Raloxifene, is a selective estrogen antagonist or estrogen strogen receptor modulator (SERM) that has been approved as a medication to prevent and treat osteoporosis in postmenopausal women.

H3B-5942 (H3B5942) is a selective, irreversible (covalent) and orally bioavailable estrogen receptor antagonist with antitumor activity (better than fulvestrant).

Diethylstilbestrol (also called Stilbestrol; DES; Distilbene) is a synthetic non-steroidal form of estrogen that can be used to prevent miscarriage and other pregnancy complications as well as in the treatment of menopausal and postmenopausal disorders.

Clomifene Citrate (NSC35770; NSC-35770; Omifin; Chloramiphene; Clomide; Clostilbegit; Clomid; Androxal; Dyneric; Gravosan; Klostilbegit; Serophene), the citrate salt of Clomifene, is a potent SERM (selective estrogen receptor modulator) that has been used in the treatment of ovulation induction.

Ospemifene (FC-1271a; FC1271a; Osphena) is an orally bioactive medication and a non-hormonal selective estrogen receptor modulator (SERM), used for the treatment of dyspareunia.

Chlorotrianisene is a long-acting, orally bioactive non-steroidal synthetic estrogen that was used for the treatment of menopause, deficiencies in ovary function, and prostate cancer.

Norethindrone acetate (NSC-22844; NSC22844; NSC 22844; ENTA) is the 17-O-acetylated ester of Norethindrone (Norethisterone; sold under many trade names), which is a synthetic progestin and an orally active contraceptive for preventing pregnancy.

Afimoxifene (4-hydroxytamoxifen or (E/Z)-4-hydroxy Tamoxifen), an active metabolite of tamoxifen with both estrogenic and anti-estrogenic effects, is a SERM (selective estrogen receptor modulator).

Pritelivir (formerly known as AIC-316; BAY-57-1293; AIC316; BAY571293) is a novel and potent helicase primase inhibitor that displays antiviral effects against herpes simplex virus (HSV) with an IC50 of 20 nM for both HSV-1 and HSV-2.